Sumona Chakraborty
Executive Director·OrbiMed
Bio
Professional summary
Sumona Chakraborty is an Executive Director on OrbiMed's Asia private equity team and joined the firm in 2018. Before OrbiMed, she worked in investment banking at Avendus Capital, Equirus Capital and UBS. Public transaction announcements name her as joining the boards of Arcatron and Pee Safe as part of OrbiMed investments.
Notable companies
Selected portfolio companies the partner has backed
Background
Career, education, and skills
Career history
- OrbiMedExecutive Director, Asia Private Equity2018 – Present
- Avendus CapitalInvestment banking
- Equirus CapitalInvestment banking
- UBSInvestment banking
Education
- National Institute of Technology, WarangalBachelor of Technology in Biotechnology
- S.P. Jain Institute of Management and Research, MumbaiM.B.A.
Other partners at OrbiMed
12 more profiles
Aditya Tolia
Private Equity Senior Analyst
OrbiMed
Private Equity Senior Analyst at OrbiMed with prior Investec and PwC banking experience.
Alexis Megibow
Private Equity Associate
OrbiMed
Private Equity Associate at OrbiMed.
Ankesh Bhansali
Managing Director
OrbiMed
OrbiMed Asia Managing Director focused on healthcare private equity.
Arun Sadhanandham
Managing Director
OrbiMed
OrbiMed Asia Managing Director investing in healthcare private equity.
Brendan Weber, CFA
Principal
OrbiMed
Principal on OrbiMed's Credit & Royalty team focused on structured credit and royalty financings.
Carl Gordon
Managing Partner
OrbiMed
OrbiMed Managing Partner leading private equity and biotech company formation.
Carl L. Gordon
Managing Partner
OrbiMed
Carl L. Gordon is a Managing Partner at OrbiMed and leads the firm's private equity team.
Carter Neild
Managing Partner
OrbiMed
OrbiMed Managing Partner focused on healthcare royalties and Asia private investments.
Clay Daniel DeMarcus
Principal
OrbiMed
Principal focused on medical technology and non-therapeutics venture investing.
Cooper Steputis
Private Equity / Venture Capital
OrbiMed
Healthcare private equity and venture investor with prior investment banking experience.
Daniel Ying
Executive Director
OrbiMed
OrbiMed Asia Executive Director focused on pharma and biotech investments.
David Bonita
General Partner
OrbiMed
OrbiMed General Partner and physician-investor in healthcare and therapeutics.